Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Walters

Showing results (771-780 of 865) with videos related to

Pageof 87
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 29, 2026
Splice isoforms of the histone variant macroH2A1 differentially regulate hippocampal gene expression and memory formationTimothy A B McLean, Zhenhong Jin, Luca A Hategan, et al.
Microbiology Resource Announcements|June 7, 2024
Complete genome sequence of a <i>Pseudomonas fluorescens</i> bacteriophage UNO-G1W1 isolated from freshwater ice in NebraskaThomas T Schulze, Andrew J Neville, Gabrielle F Watson, et al.
Advances in Radiation Oncology|July 26, 2023
Near-Surface Dose Correlates With Moist Desquamation and Unplanned Reconstructive Surgery in Patients With Implant-Based Reconstruction Receiving Postmastectomy Radiation TherapyRonald Levitin, Kamran Salari, Bryan S Squires, et al.
Cancer Cell|December 17, 2013
A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancerRavi K Anchoori, Balasubramanyam Karanam, Shiwen Peng, et al.
Cell Reports|August 17, 2023
A planar polarized MYO6-DOCK7-RAC1 axis promotes tissue fluidification in mammary epitheliaLuca Menin, Janine Weber, Stefano Villa, et al.
Trials|June 14, 2017
Choosing the target difference ('effect size') for a randomised controlled trial - DELTA<sup>2</sup> guidance protocolJonathan A Cook, Steven A Julious, William Sones, et al.
Trials|October 12, 2018
Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA<sup>2</sup> guidanceWilliam Sones, Steven A Julious, Joanne C Rothwell, et al.
Trials|October 26, 2019
Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidanceWilliam Sones, Steven A Julious, Joanne C Rothwell, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonistsGillian E Lunniss, Ashley A Barnes, Nick Barton, et al.
Metabolism: Clinical and Experimental|August 20, 2013
Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetesTimothy J Sullivan, Zhenhua Miao, Bin N Zhao, et al.
Pageof 87

Showing results (771-780 of 865) with videos related to

Sort By:
Pageof 87
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 29, 2026
Splice isoforms of the histone variant macroH2A1 differentially regulate hippocampal gene expression and memory formationTimothy A B McLean, Zhenhong Jin, Luca A Hategan, et al.
Microbiology Resource Announcements|June 7, 2024
Complete genome sequence of a <i>Pseudomonas fluorescens</i> bacteriophage UNO-G1W1 isolated from freshwater ice in NebraskaThomas T Schulze, Andrew J Neville, Gabrielle F Watson, et al.
Advances in Radiation Oncology|July 26, 2023
Near-Surface Dose Correlates With Moist Desquamation and Unplanned Reconstructive Surgery in Patients With Implant-Based Reconstruction Receiving Postmastectomy Radiation TherapyRonald Levitin, Kamran Salari, Bryan S Squires, et al.
Cancer Cell|December 17, 2013
A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancerRavi K Anchoori, Balasubramanyam Karanam, Shiwen Peng, et al.
Cell Reports|August 17, 2023
A planar polarized MYO6-DOCK7-RAC1 axis promotes tissue fluidification in mammary epitheliaLuca Menin, Janine Weber, Stefano Villa, et al.
Trials|June 14, 2017
Choosing the target difference ('effect size') for a randomised controlled trial - DELTA<sup>2</sup> guidance protocolJonathan A Cook, Steven A Julious, William Sones, et al.
Trials|October 12, 2018
Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA<sup>2</sup> guidanceWilliam Sones, Steven A Julious, Joanne C Rothwell, et al.
Trials|October 26, 2019
Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidanceWilliam Sones, Steven A Julious, Joanne C Rothwell, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonistsGillian E Lunniss, Ashley A Barnes, Nick Barton, et al.
Metabolism: Clinical and Experimental|August 20, 2013
Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetesTimothy J Sullivan, Zhenhua Miao, Bin N Zhao, et al.
Pageof 87